<DOC>
	<DOCNO>NCT00348673</DOCNO>
	<brief_summary>A phase 2a study investigate effect 7-day monotherapy UK-453,061 viral load response asymptomatic human immunodeficiency virus ( HIV ) infect subject , assess dose-response relationship , ass pharmacokinetics ( PK ) , safety tolerability UK-453,061 asymptomatic HIV infect subject .</brief_summary>
	<brief_title>A Study Asymptomatic HIV Infected Patients Investigate Pharmacodynamics , Pharmacokinetics , Safety Toleration UK-453,061</brief_title>
	<detailed_description />
	<criteria>Asymptomatic HIV1 infect male patient age 1855 year inclusive . Patients virus contain NNRTI resistant mutation determine VircoGEN virtual phenotyping essay . Patients CD4 count le 250 cells/mm3 . Patients whose HIV infection diagnose less 3 month prior screen , evidence recent seroconversion . Patients HIV viral load less 5000 copies/ml use RTPCR ( Roche Amplicor v1.5 ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>